Abstract This review aimed to identify the impact of the ECHO® model on monitoring people diagnosed with diabetes mellitus. It followed the Joanna Briggs Institute and the PRISMA-ScR Checklist. The search was conducted in the Cochrane Library, Embase, Virtual Health Library, PubMed/MEDLINE, Scopus, and Web of Science databases. The strategy included the descriptors “Diabetes mellitus,” “Diabetes Melito,” “Diabetes,” “Diabetes Melito,” “Model ECHO,” “Project ECHO,” and “Extension for Community Healthcare Outcomes.” Two independent reviewers selected the studies using the Rayyan-Intelligent Systematic Review management software. Nine of the 151 studies initially identified were selected, and one study was identified through gray literature. The ten studies were published in English between 2012 and 2022. Improvements were found in the professionals’ knowledge and self-confidence, besides decreased glycated hemoglobin levels, hospital admissions, and hospitalization costs among people with diabetes. The conclusion is that the ECHO® Model positively impacted the monitoring of people with diabetes mellitus, especially in vulnerable communities.

Resumo A presente revisão teve como objetivo identificar o impacto do modelo ECHO® no acompanhamento de pessoas com diagnóstico de diabetes mellitus. O trabalho foi desenvolvido de acordo com as recomendações do Joanna Briggs Institute e do Checklist PRISMA-ScR, cujas buscas foram realizadas nas bases de dados Cochrane Library, Embase, Biblioteca Virtual em Saúde, PubMed/MEDLINE, Scopus e Web of Science, por meio de estratégias compostas pelos descritores “Diabetes mellitus”, “Diabete Melito”, “Diabetes”, “Diabetes Melito”, “model ECHO”, “Project ECHO” e “Extension for Community Healthcare Outcomes”. A seleção dos estudos contou com dois revisores trabalhando de forma independente através do software de gestão Rayyan-Intelligent Systematic Review. Dos 151 trabalhos identificados, nove foram selecionados. Um estudo foi identificado na literatura cinzenta. Os dez estudos incluídos foram publicados em inglês, entre os anos de 2012 a 2022. Observou-se melhorias no conhecimento e na autoconfiança dos profissionais, além de diminuição da hemoglobina glicada, redução de hospitalizações e de gastos com internações das pessoas com diabetes. Conclui-se que este trabalho expõe um impacto positivo do Modelo ECHO® no acompanhamento de pessoas com diabetes mellitus, principalmente em comunidades de maior vulnerabilidade.

Resumen La presente revisión tuvo como objetivo identificar el impacto del modelo ECHO® en el seguimiento de personas diagnosticadas con diabetes mellitus. El trabajo se desarrolló de acuerdo con las recomendaciones del Instituto Joanna Briggs y el PRISMA-ScR Checklist, cuyas búsquedas se realizaron en las bases de datos Cochrane Library, Embase, Biblioteca Virtual de Salud (BVS), PubMed/MEDLINE, Scopus y Web of Science, mediante estrategias compuestas por los descriptores “Diabetes mellitus”, “Diabete Melito”, “Diabetes”, “Diabetes Melito”, “model ECHO”, “Project ECHO” y “Extension for Community Healthcare Outcomes”. La selección de estudios incluyó a dos revisores que trabajaron de forma independiente utilizando el software de gestión Rayyan-Intelligent Systematic Review. Se seleccionaron nueve de las 151 obras identificadas y se identificó un estudio por medio de la literatura gris. Los diez estudios incluidos fueron publicados en inglés entre 2012 y 2022. Se observaron mejoras en el conocimiento y la confianza en sí mismos de los profesionales, además de una reducción de la hemoglobina glucosilada, de las hospitalizaciones y de los costos de hospitalización de las personas con diabetes. Se concluye que este trabajo expuso un impacto positivo del Modelo ECHO® en el seguimiento de personas con diabetes mellitus, especialmente en comunidades más vulnerables.

Abstract Aim To evaluate the clinical effectiveness of ozonated sunflower oil (Oz) as an adjunctive of non-surgical periodontal therapy in patients with type 2 diabetes mellitus (DM2), on fibroblast cell viability and migration and the effectiveness of Oz on a Candida albicans (C. albicans) culture. Methodology In total, 32 sites in 16 DM2 with moderate to advanced periodontal disease with periodontal pocket depths ≥5mm were selected. The treatments were divided into two groups: control, saline solution (SS) as an adjunctive of scaling and root planing (SRP+SS), and test, Oz as an adjunctive of SRP (SRP+Oz). Hematological [fasting glucose level (FGL) and hemoglobin A1c (HbA1c)] and microbiological samples were collected from the participants at baseline and three months after periodontal treatment and the microbiological samples were analyzed by PCR. C. albicans was previously tested by the agar diffusion test. The effect of Oz was tested on cell viability and fibroblast migration. Results The groups showed no statistically significant differences (paired t-test-p>0.05) regarding hematological parameters, FGL (median - baseline 171.41, 3 months 164mg/dL), and HbA1c (baseline 8%, 3 months 7.5%) (Kruskal-Wallis One-Way Nonparametric-p>0.05) after periodontal therapy. The groups showed statistical differences for periodontal parameters between baseline and three months (paired t-test-p<0.05). PCR analysis showed a reduction in the percentage of C. albicans in the SRP+Oz group after three months (McNemar’s test-p=0.002). Cell viability was lower in the high glucose Dulbecco’s modified Eagle’s medium (4500 mg/L) than in low glucose (1000 mg/L) (RM-ANOVA-p<0.0001). The wound healing test showed reduced fibroblast migration (one-way ANOVA with Dunnett’s post-test-p<0.01). Oz showed high C. albicans antifungal inhibition (Kruskal-Wallis test-p=0.0001). Conclusions SRP+Oz effectively reduced C. albicans in-vitro and in-vivo but showed no clinical improvements compared to the control. Cell viability and wound healing of fibroblasts showed no improvements.

RESUMO Objetivo: A brucelose é uma doença infecciosa multissistêmica e pode causar aumento dos reagentes de fase aguda. Este estudo teve como objetivo examinar o índice de massa plaquetária (PMI, platelet mass index), a relação neutrófilos-linfócitos (NLR, neutrophil-lymphocyte ratio) e o índice de inflamação imunológica sistêmica (SII, systemic immune-inflammation index) em crianças com brucelose, e determinar seus papéis no envolvimento focal. Métodos: Este estudo observacional retrospectivo incluiu 69 pacientes com brucelose e um grupo controle de 69 crianças saudáveis. Marcadores de inflamação, PMI, NLR e SII foram comparados em pacientes com brucelose e grupo controle e em pacientes com brucelose com e sem envolvimento focal. Resultados: Os valores de hemoglobina e plaquetas foram significativamente menores nos casos de brucelose em comparação ao grupo controle (p<0,001), e proteína C-reativa e ferritina foram significativamente maiores (p<0,001). O SII e o PMI foram significativamente menores no grupo de pacientes com brucelose em comparação ao grupo controle (p<0,001). Na comparação dos casos com e sem envolvimento focal, não foi detectada diferença estatisticamente significativa nos parâmetros hematológicos e marcadores de inflamação. Conclusões: Este estudo mostrou que o PMI, um dos novos marcadores que podem ser calculados a partir do hemograma completo, pode ser útil no diagnóstico da brucelose infantil. Resultados semelhantes não puderam ser alcançados para NLR e SII. Novos estudos são necessários para testar o valor diagnóstico de PMI, NLR e SII na brucelose infantil.

ABSTRACT Objective: Brucellosis is a multisystem infectious disease and may cause an increase in acute phase reactants. This study aimed to examine the platelet mass index (PMI), the neutrophil-lymphocyte ratio (NLR), and systemic immune-inflammation index (SII) in children with brucellosis and to determine their roles in focal involvement. Methods: This retrospective observational study included 69 patients with brucellosis and a control group of 69 healthy children. Inflammation markers, PMI, NLR, and SII were compared in brucellosis patients and the control group and in brucellosis patients with and without focal involvement. Results: Hemoglobin and platelet values were significantly lower in brucellosis cases compared to the control group (p<0.001), and C-reactive protein and ferritin were significantly higher (p<0.001). SII and PMI were significantly lower in the brucellosis patient group compared to the control group (p<0.001). In the comparing cases with and without focal involvement, no statistically significant difference was detected in hematological parameters and inflammation markers. Conclusions: This study showed that PMI, one of the new markers that can be calculated from complete blood count, may be useful in diagnosing childhood brucellosis. Similar results could not be reached for NLR and SII. New studies testing the diagnostic value of PMI, NLR, and SII in childhood brucellosis are needed.

RESUMO: O objetivo foi avaliar parâmetros hematológicos e bioquímicos após teste em novo ambiente, e o desempenho zootécnico de Oreochromis niloticus classificado como proativo ou reativo. No experimento 1, machos de tilápia do Nilo com peso médio de 128,33 ± 34,17 g foram mantidos em sistema de recirculação de água (RAS). Imediatamente após a classificação, foram coletadas amostras de sangue de 20 animais reativos e 20 proativos. No experimento 2 foram classificados 60 machos proativos e 60 reativos, com peso médio de 88,23 ± 21,59 g, os quais foram divididos nos seguintes tratamentos: PT (40 animais proativos), RT (40 reativos) MT (20 proativos + 20 reativos). Os animais foram alimentados duas vezes ao dia durante 90 dias. No experimento 1, os animais reativos apresentaram maior hemoglobina e cortisol e menor quantidade de leucócitos. No experimento 2, o ganho em peso foi maior nos animais proativos (PT) e nos animais reativos (RT); porém, a melhor conversão alimentar foi obtida nos animais reativos. A taxa de sobrevivência foi menor no grupo de animais do tratamento MT. Já a hemoglobina e a glicose tiveram valores inferiores para os animais proativos e para aqueles que estavam misturados, no grupo MT. O colesterol foi superior nos animais PT. Conclui-se que variáveis como hemoglobina, cortisol, leucócitos e colesterol têm maior probabilidade de sofrer alterações entre traços de personalidade. Ainda, pode-se concluir que O. niloticus reativos e proativos, cultivados em ambientes separados, apresentam o mesmo potencial de ganho em peso, porém, a conversão alimentar dos reativos é melhor. RESUMO ambiente reativo 1 12833 128 33 128,3 3417 34 17 34,1 RAS. RAS . (RAS) classificação 6 8823 88 23 88,2 2159 21 59 21,5 tratamentos 40 (4 , proativos) (2 9 dias (PT (RT) porém misturados Concluise Conclui se personalidade Ainda podese pode separados 1283 12 3 128, 341 34, (RAS 882 8 88, 215 5 21, 4 ( (RT

ABSTRACT: To evaluate hematological and biochemical parameters after testing in a new environment, and the zootechnical performance of Oreochromis niloticus classified as proactive or reactive. In experiment 1, male Nile tilapia with an average weight of 128.33 ± 34.17 g were kept in a recirculating aquaculture system (RAS). Immediately after classification, blood samples were collected from 20 reactive and 20 proactive animals. In experiment 2, 60 proactive and 60 reactive males were classified, with an average weight of 88.23 ± 21.59 g, which were divided into the following treatments: PT (40 proactive animals), RT (40 reactive) MT (20 proactive + 20 reactive ). Animals were fed twice daily for 90 days. In experiment 1, reactive animals had higher amounts of hemoglobin and cortisol and lower amounts of leukocytes detected. In experiment 2, weight gain was greater in proactive animals (PT) and reactive animals (RT); however, the best feed conversion was obtained in reactive animals. The survival rate was lower in the MT treatment group of animals. Hemoglobin and glucose had lower values for proactive animals and for those that were mixed, in the MT group. Cholesterol was higher in animals PT. It is concluded that variables such as hemoglobin, cortisol, leukocytes and cholesterol are more likely to undergo changes between personality traits. Furthermore, it can be concluded that reactive and proactive O. niloticus, grown in separate environments, have the same potential for weight gain; however, the food conversion of reactive ones is better. ABSTRACT environment 1 12833 128 33 128.3 3417 34 17 34.1 RAS. RAS . (RAS) classification 2 6 8823 88 23 88.2 2159 21 59 21.5 treatments 40 (4 animals, , animals) (2 ) 9 days detected (PT (RT) however mixed traits Furthermore O environments better 1283 12 3 128. 341 34. (RAS 882 8 88. 215 5 21. 4 ( (RT

Resumo A presente revisão teve como objetivo identificar o impacto do modelo ECHO® no acompanhamento de pessoas com diagnóstico de diabetes mellitus. O trabalho foi desenvolvido de acordo com as recomendações do Joanna Briggs Institute e do Checklist PRISMA-ScR, cujas buscas foram realizadas nas bases de dados Cochrane Library, Embase, Biblioteca Virtual em Saúde, PubMed/MEDLINE, Scopus e Web of Science, por meio de estratégias compostas pelos descritores “Diabetes mellitus”, “Diabete Melito”, “Diabetes”, “Diabetes Melito”, “model ECHO”, “Project ECHO” e “Extension for Community Healthcare Outcomes”. A seleção dos estudos contou com dois revisores trabalhando de forma independente através do software de gestão Rayyan-Intelligent Systematic Review. Dos 151 trabalhos identificados, nove foram selecionados. Um estudo foi identificado na literatura cinzenta. Os dez estudos incluídos foram publicados em inglês, entre os anos de 2012 a 2022. Observou-se melhorias no conhecimento e na autoconfiança dos profissionais, além de diminuição da hemoglobina glicada, redução de hospitalizações e de gastos com internações das pessoas com diabetes. Conclui-se que este trabalho expõe um impacto positivo do Modelo ECHO® no acompanhamento de pessoas com diabetes mellitus, principalmente em comunidades de maior vulnerabilidade.

Resumen La presente revisión tuvo como objetivo identificar el impacto del modelo ECHO® en el seguimiento de personas diagnosticadas con diabetes mellitus. El trabajo se desarrolló de acuerdo con las recomendaciones del Instituto Joanna Briggs y el PRISMA-ScR Checklist, cuyas búsquedas se realizaron en las bases de datos Cochrane Library, Embase, Biblioteca Virtual de Salud (BVS), PubMed/MEDLINE, Scopus y Web of Science, mediante estrategias compuestas por los descriptores “Diabetes mellitus”, “Diabete Melito”, “Diabetes”, “Diabetes Melito”, “model ECHO”, “Project ECHO” y “Extension for Community Healthcare Outcomes”. La selección de estudios incluyó a dos revisores que trabajaron de forma independiente utilizando el software de gestión Rayyan-Intelligent Systematic Review. Se seleccionaron nueve de las 151 obras identificadas y se identificó un estudio por medio de la literatura gris. Los diez estudios incluidos fueron publicados en inglés entre 2012 y 2022. Se observaron mejoras en el conocimiento y la confianza en sí mismos de los profesionales, además de una reducción de la hemoglobina glucosilada, de las hospitalizaciones y de los costos de hospitalización de las personas con diabetes. Se concluye que este trabajo expuso un impacto positivo del Modelo ECHO® en el seguimiento de personas con diabetes mellitus, especialmente en comunidades más vulnerables.

Abstract This review aimed to identify the impact of the ECHO® model on monitoring people diagnosed with diabetes mellitus. It followed the Joanna Briggs Institute and the PRISMA-ScR Checklist. The search was conducted in the Cochrane Library, Embase, Virtual Health Library, PubMed/MEDLINE, Scopus, and Web of Science databases. The strategy included the descriptors “Diabetes mellitus,” “Diabetes Melito,” “Diabetes,” “Diabetes Melito,” “Model ECHO,” “Project ECHO,” and “Extension for Community Healthcare Outcomes.” Two independent reviewers selected the studies using the Rayyan-Intelligent Systematic Review management software. Nine of the 151 studies initially identified were selected, and one study was identified through gray literature. The ten studies were published in English between 2012 and 2022. Improvements were found in the professionals’ knowledge and self-confidence, besides decreased glycated hemoglobin levels, hospital admissions, and hospitalization costs among people with diabetes. The conclusion is that the ECHO® Model positively impacted the monitoring of people with diabetes mellitus, especially in vulnerable communities.

Resumo: Introdução : A anemia é um distúrbio altamente prevalente. A anemia pré-operatória está associada a maior mortalidade, mais complicações, tempo prolongado de internação e maiores custos de saúde. A transfusão de glóbulos vermelhos (TGV) não melhora esses resultados. A Organização Mundial da Saúde recomenda a implementação de medidas de Gerenciamento de Sangue do Paciente (GSP), pois permitem melhorar esses resultados clínicos, reduzir TGV desnecessárias e economizar custos. Apesar da evidência contundente, a implementação dessas medidas ainda está aquém de ser efetivada. O objetivo deste trabalho é realizar uma análise da situação para conscientizar sobre o problema e incentivar a implementação dessas medidas. Metodologia: Foi realizado um estudo observacional, longitudinal, retrospectivo de coorte histórica, unicêntrico. Foram incluídos todos os pacientes submetidos a cirurgias de coordenação de 01/01/2022 a 01/04/2022 no Hospital de Clínicas. Critérios de exclusão: ausência de hemograma nos três meses anteriores à cirurgia e recusa em participar do estudo. Resultados: Foram analisadas um total de 329 cirurgias. 52 a cada 100 procedimentos foram realizados em pacientes com anemia. Foi encontrada uma associação estatisticamente significativa entre a anemia pré-operatória e a recepção de TGR durante a internação. OR 11,746 (4,518 - 30,540). A anemia e as TGR prolongaram significativamente a internação hospitalar. Dias de internação em função da condição do paciente: Sem anemia: 10,1 ± 1,1 dias, com anemia: 27,2 ± 2,3 dias. Valor p < 0,001. Não transfundidos: 14,5 ± 1,3 dias, transfundidos: 41,8 ± 4,4 dias. Valor p < 0,001. Apenas 49 (28,6%) dos 171 pacientes com anemia tinham metabolismo do ferro antes da cirurgia. Dos 140 pacientes com Hb < 12 mg/dL submetidos a cirurgias com sangramento não insignificante, 4 receberam tratamento específico para otimizar a Hb. Foram administradas um total de 185 unidades de glóbulos vermelhos (UGV) durante a internação. 49 em pacientes instáveis (intraoperatório ou hemorragia aguda) e 136 em pacientes estáveis. Da análise desses últimos, 42,5% dos pacientes receberam 3 ou mais UGV. A hemoglobina pré-transfusional média foi de 7,0 ± 0,1. Foi encontrada uma associação estatisticamente significativa entre receber UGV e falecer durante a internação. OR 17,182 (3,360 - 87,872). Conclusões: Foi realizado uma análise da situação na qual foi observada uma elevada prevalência de anemia pré-operatória, um estudo e tratamento escasso da anemia antes das cirurgias e uma quantidade excessiva de UGV recebidas por alguns pacientes. Este trabalho estabelece a necessidade de implementar programas de Gerenciamento de Sangue do Paciente para reduzir a prevalência de anemia pré-operatória e melhorar nossas práticas transfusionais. Além disso, estabelece um quadro comparativo para avaliar o progresso dessas medidas e aponta possíveis indicadores para avaliar os benefícios de sua implementação.

Abstract: Introduction: Anemia is a highly prevalent disorder. Preoperative anemia is associated with higher mortality, more complications, longer hospital stays, and higher healthcare costs. Red blood cell transfusion (RBC) does not improve these outcomes. The World Health Organization recommends implementing Patient Blood Management (PBM) programmes, as they can improve these clinical outcomes, reduce unnecessary RBC transfusions, and save costs. Despite compelling evidence, the implementation of these measures has yet to be effectively achieved. The objective of this study is to conduct a situational analysis to raise awareness about this issue and encourage the implementation of these measures. Methodology: An observational, longitudinal, retrospective cohort study was conducted at a single center. All patients undergoing elective surgery from 01/01/2022 to 01/04/2022 at the Hospital de Clínicas were included. Exclusion criteria: absence of a complete blood count in the three months prior to surgery and refusal to participate in the study. Results: A total of 329 surgeries were analyzed. 52 out of 100 procedures were performed on patients with anemia. A statistically significant association was found between preoperative anemia and receiving RBC transfusion during hospitalization. OR 11.746 (4.518 - 30.540). Anemia and RBC transfusions significantly prolonged hospital stay. Length of hospitalization based on patient condition: No anemia: 10.1 ± 1.1 days, with anemia: 27.2 ± 2.3 days. Value of p < 0.001. Non-transfused: 14.5 ± 1.3 days, transfused: 41.8 ± 4.4 days. Value of p < 0.001. Only 49 (28.6%) of the 171 patients with anemia had iron metabolism assessed before surgery. Among the 140 patients with Hb < 12 g/dL undergoing surgeries with non-insignificant bleeding, only 4 received specific treatment to optimize Hb. A total of 185 units of red blood cells (RBC) were administered during hospitalization. 49 to unstable patients (intraoperative or acute hemorrhage) and 136 to stable patients. From the analysis of the latter group, 42.5% of the patients received 3 or more RBC units. The average pre-transfusion hemoglobin was 7.0 ± 0.1. A statistically significant association was found between receiving RBC units and dying during hospitalization. OR 17.182 (3.360 - 87.872). Conclusiones: A situational analysis was conducted, revealing a high prevalence of preoperative anemia, scarce study and treatment of anemia before surgeries, and an excessive amount of blood transfusions received by some patients. This work establishes the need to implement Patient Blood Management programs to reduce the prevalence of preoperative anemia and improve our transfusion practices. It also sets a comparative framework to evaluate the progress of these measures and indicates possible indicators to assess the benefits of their implementation.

resumen está disponible en el texto completo

Resumen Objetivo: recopilar información de factores de riesgo de la enfermedad arterial coronaria en población adulta evidenciados mediante estudios de aleatorización mendeliana. Métodos: de acuerdo con las recomendaciones de la escala para la Evaluación de Artículos de Revisión Narrativa (SANRA), se realizó una revisión desde el usuario de la Universidad Militar Nueva Granada en las bases de datos de PubMed, EMBASE y BIREME. Resultados: se obtuvieron 757 artículos, luego se aplicaron los criterios de inclusión y exclusión, y se eligieron 29 artículos en los que se investiga la asociación de la enfermedad arterial coronaria con la apolipoproteína B, colesterol LDL, triglicéridos, colesterol total, apolipoproteina C3, proteína de transferencia de ésteres de colesterol, HDL, omega 6, lipoproteína (a), obesidad, hemoglobina A1C, diabetes mellitus tipo 2, glucosa en ayunas, inicio del hábito de fumar, presión arterial, hormona paratiroidea sérica, niveles de fosfato sérico, enfermedad del hígado graso no alcohólico, síndrome de ovario poliquístico, globulina fijadora de hormonas sexuales, testosterona, filoquinona circulante, proteína gla de la matriz inactiva, antioxidantes circulantes derivados de la dieta, glicina, homocisteína, ácido úrico, marcadores inflamatorios, hemoglobina, hematocrito y recuento de glóbulos rojos. Conclusión: esta revisión sugiere nuevos estudios con información genética colombiana para respaldar los factores de riesgo aquí presentados, teniendo en cuenta que en ninguno de los estudios evaluados se utilizó información genética latinoamericana, lo cual puede limitar la extrapolación de los resultados.

Summary: Objective: To compile information on risk factors for coronary artery disease in the adult population evidenced by Mendelian randomization studies.. Methods: A search was carried out from the user of the Nueva Granada Military University in the databases of PubMed, EMBASE and BIREME and a narrative review of the literature was carried out in accordance with the recommendations of the scale for the Evaluation of Narrative Review Articles (SANRA). Results: 757 articles were obtained, after the application of inclusion and exclusion criteria, 29 articles were chosen that investigated the association of apolipoprotein B, LDL cholesterol, triglycerides, total cholesterol, apolipoprotein C3, cholesterol ester transfer protein, HDL, omega 6, lipoprotein (a), obesity, hemoglobin A1C, type 2 diabetes mellitus, fasting glucose, smoking initiation, blood pressure, serum parathyroid hormone, serum phosphate levels, non-alcoholic fatty liver disease, polycystic ovary syndrome , sex hormone-binding globulin, testosterone, circulating phylloquinone, inactive matrix protein gla, circulating dietary-derived antioxidants, glycine, homocysteine, uric acid, inflammatory markers, hemoglobin, hematocrit, and red blood cell count, with coronary artery disease. Conclusion: This review suggests new studies with Colombian genetic information to support the risk factors presented here, considering that none of the studies evaluated used Latin American genetic information, which may limit the extrapolation of the results.

Resumen Introducción: la organización mundial de la salud estima que 2000 millones de personas padecen anemia, mientras que la pre-diabetes y la diabetes afectan aproximadamente a 352 y 460 millones de personas, respectivamente. La anemia es una complicación frecuente en la diabetes mellitus (DM). Objetivo: evaluar la asociación y probabilidad de alteraciones de la hemoglobina en pre-diabéticos y diabéticos. Metodología: estudio descriptivo, retorspectivo y transversal, la población fue de 1103 pacientes (211 prediabéticos, 223 diabéticos y 669 normoglucémicos), la muestra fue el total de la población que cumplió con los criterios de inclusión y exclusión: adultos normoglucémicos y pre-diabéticos sin presencia de enfermedad aguda o crónica al momento del examen. La asociación entre variables se realizó por medio de la prueba de chi-cuadrado y la probabilidad fue determinada por la prueba de Odds Ratio. Resultados: las mujeres pre-diabéticas tuvieron una probabilidad 1.72 mayor de anemia que mujeres no diabéticas. Los hombres pre-diabéticos tuvieron una probabilidad 2.80 veces mayor de anemia que los no diabéticos. Las mujeres diabéticas tuvieron una probabilidad 2,37 más alta de tener anemia, mientras que los hombres diabéticos tuvieron una probabilidad 4,41 veces más alta que lo hombres no diabéticos de padecer anemia. Conclusiones: pacientes pre-diabéticos tienen mayor probabilidad de anemia que en no diabéticos. Es posible que la hiperglucemia persistente en pre-diabéticos se asocie a cambios en la concentración de esta hemoproteína años antes del desarrollo de diabetes por mecanismos similares, pero de forma incipiente.

Abstract Introduction: The World Health Organization estimates that 2 billion people suffer from anemia, while pre-diabetes and diabetes affect approximately 352 and 460 million people, respectively. Anemia is a frequent complication in diabetes mellitus. Objective: To evaluate the association and probability of hemoglobin alterations in pre-diabetics and diabetics. Methodology: Descriptive, retrospective and cross-sectional study, the population was 1103 patients (211 prediabetics, 223 diabetics and 669 normoglycemics), the sample was the total population that met the inclusion and exclusion criteria: normoglycemic and prediabetic adults without presence of acute or chronic disease at the time of examination. The association between variables was performed using the chi-square test and the probability was determined by the Odds Ratio test. Results: Pre-diabetic women had a 1.72 higher probability of anemia than non-diabetic women. Pre-diabetic men were 2.80 times more likely to have anemia than non-diabetics. Diabetic women were 2.37 times more likely to have anemia, while diabetic men were 4.41 times more likely than non-diabetic men to have anemia. Conclusions: Pre-diabetic patients are more likely to have anemia than non-diabetics. It is possible that persistent hyperglycemia in pre-diabetics is associated with changes in the concentration of this hemoprotein years before the development of diabetes by similar mechanisms, but in an incipient manner.

Resumen Introducción. Existe una gran preocupación humana por la resistencia a los antibióticos debido a su uso inadecuado como promotores del crecimiento en la cría de animales. Objetivo. Evaluar el efecto de altos niveles de zinc como sustituto del antibiótico en lechones destetados. Material y métodos. El estudio se realizó de junio a agosto de 2022 en la provincia de Chiriquí, Panamá. El periodo experimental estuvo compuesto por tres fases con 14 días por fase. Los cerdos destetados (n= 54) fueron asignados a uno de tres tratamientos con seis repeticiones por tratamiento y tres cerdos por repetición. Los tratamientos fueron: 1) dieta control, formulada para suplir los requerimientos nutricionales para cerdos destetados; 2) similar al tratamiento 1, más 200 mg de amoxicilina/kg de alimento y 40 mg de florfenicol/kg de alimento durante la fase 1 (P1) y fase 2 (P2), respectivamente; y 3) similar al tratamiento 1, más 2000 ppm y 1600 ppm de zinc durante P1 y P2, respectivamente. En la fase 3 (P3), todos los cerdos fueron alimentados con una dieta común. Resultados. La suplementación con zinc mejoró la ganancia de peso en todas las fases. Los cerdos alimentados con zinc tuvieron mejor relación F:G en P2 en comparación a los cerdos suplementados con antibiótico (p < 0.05). Se encontró una mayor concentración de hemoglobina y porcentaje de monocitos en cerdos alimentados con zinc que en los otros tratamientos (p < 0.05). Los cerdos alimentados con antibiótico o la dieta control tuvieron un menor porcentaje de materia seca fecal en comparación a los suplementados con zinc (p < 0.05). Conclusión. La suplementación de altos niveles de zinc ejerció mejoras, en comparación al antibiótico, en cuanto a la concentración de hemoglobina, incidencia de diarrea y ganancia de peso en cerdos durante los 42 días posteriores al destete.

Abstract Introduction. There is a great human concern about antibiotics resistance due to their inappropriate use as growth promoters in animal husbandry. Objective. To evaluate the effect of a high level of zinc as a substitute to antibiotics in nursery pigs. Material and methods. The study was carried out from June to August 2022 in the province of Chiriqui, Panama. The experimental period was composed of three phases with 14 days per phase. The nursery pigs (n= 54) were distributed to one of three treatments with six replicates per treatment and three pigs per replicate. The treatments were: 1) control diet, which was formulated to meet the nutritional requirements for nursery pigs; 2) similar to treatment 1, plus 200 mg of amoxicillin/kg of feed and 40 mg of florfenicol/kg of feed during phase 1 (P1) and phase 2 (P2), respectively; and 3) similar to treatment 1, plus 2000 ppm and 1600 ppm of zinc during P1 and P2, respectively. In phase 3 (P3), all pigs were fed a common diet. Results. The supplementation of zinc improved the average daily gain in all phases. Pigs fed zinc diet had better F:G ratio in P2 compared to pigs fed antibiotic diet (p < 0.05). A higher concentration of hemoglobin and percentage of monocytes was found in pigs fed with higher level of zinc than the other treatments (p < 0.05). Furthermore, Pigs fed the antibiotic, or the control diet had a lower percentage of fecal dry matter compared to those supplemented with zinc. (p < 0.05). Conclusion. The supplementation of high levels of zinc exerted improvements, in comparison to the antibiotic, in terms of hemoglobin concentration, incidence of diarrhea and weight gain in pigs during 42 days after weaning.

RESUMEN Introducción: La diabetes mellitus tipo 2 (DM2) es un problema de salud pública creciente, frecuentemente asociada con sobrepeso y obesidad. El índice de masa corporal (IMC) y la hemoglobina glicosilada (HbA1c) son indicadores clave en el manejo de la DM2. Objetivo: Correlacionar el IMC y la HbA1c en pacientes con DM2 atendidos en el Hospital Distrital de Capiatá, Paraguay, en diciembre de 2022. Materiales y métodos: Estudio correlacional con datos secundarios de 38 pacientes DM2. Se recolectaron datos demográficos, clínicos, antropométricos y bioquímicos. Se utilizó la correlación de Pearson para determinar la correlación entre IMC y HbA1c, con un nivel de significancia de p<0,05. El protocolo de investigación fue aprobado por el Comité de Ética en Investigaciones de la FCQ-UNA (CEI913/2022). Resultados: El 65,8% fueron mujeres, con edad promedio de 55,8±5,2 años. El 86,8% presentó exceso de peso. La glucemia en ayunas promedio fue 245,0±57,0mg/dL y la HbA1c 8,8±3,4%. Se observó una tendencia al aumento de los niveles de HbA1c con el incremento del IMC. Los pacientes con peso normal presentaron una HbA1c promedio de 6,8±1,5% (buen control), mientras que aquellos con sobrepeso y obesidad mostraron valores de 8,6±2,7% (mal control) y 11,2±3,0% (control crítico), respectivamente. Estas diferencias resultaron estadísticamente significativas (p<0,01). Se observó una correlación fuerte y significativa entre IMC y HbA1c (r=0,681, p<0,01). Conclusión: Existe una correlación directamente proporcional entre el IMC y el control glucémico en pacientes con DM2. Estos hallazgos resaltan la importancia del control del peso en el manejo de la DM2.

ABSTRACT Introduction: Type 2 diabetes mellitus (T2DM) is a growing public health problem, frequently associated with overweight and obesity. Body mass index (BMI) and glycated hemoglobin (HbA1c) are key indicators in the management of T2DM. Objective: To correlate BMI and HbA1c in patients with DM2 treated at the Capiatá District Hospital, Paraguay, in December 2022. Materials and methods: Correlational study with secondary data from 38 DM2 patients. Demographic, clinical, anthropometric and biochemical data were collected. Pearson's correlation was used to determine the correlation between BMI and HbA1c, with a significance level of p<0.05. The research protocol was approved by the Research Ethics Committee of the FCQ-UNA (CEI913/2022). Results: 65.8% were women, with an average age of 55.8±5.2 years. 86.8% were overweight. The average fasting blood glucose was 245.0±57.0mg/dL and the HbA1c was 8.8±3.4%. A tendency to increase HbA1c levels with increasing BMI was observed. Patients with normal weight had an average HbA1c of 6.8±1.5% (good control), while those with overweight and obesity showed values of 8.6±2.7% (poor control) and 11.2± 3.0% (critical control), respectively. These differences were statistically significant (p<0.01). A strong and significant correlation was observed between BMI and HbA1c (r=0.681, p<0.01). Conclusion: There is a directly proportional correlation between BMI and glycemic control in patients with DM2. These findings highlight the importance of weight control in the management of T2DM.

RESUMEN Introducción: La esclerosis glomerular focal y segmentaria (FSGS) es una de las glomerulonefritis más comunes. Se han propuesto varios mecanismos que podrían contribuir a la falta de respuesta al tratamiento en la FSGS primaria, tales como la cantidad de proteinuria basal, la tasa de esclerosis histopatológica y la presencia de pacientes no diagnosticados con FSGS secundaria. En este estudio, nuestro objetivo fue investigar los posibles factores que afectan la respuesta al tratamiento en la FSGS primaria. Métodos: Nuestro estudio es una cohorte retrospectiva de un solo centro que incluye pacientes diagnosticados con esclerosis glomerular focal y segmentaria mediante biopsias renales entre 2008 y 2018. Se identificaron un total de 185 pacientes diagnosticados con FSGS. Se registraron los subtipos de FSGS de estos pacientes. Se incluyeron 57 pacientes con un seguimiento y antecedentes de tratamiento completos. Cuarenta y uno de estos pacientes tenían FSGS primaria y 16 FSGS secundaria. Se analizaron las características basales, los parámetros de laboratorio, los hallazgos histopatológicos y los tratamientos iniciales en pacientes con FSGS primaria. Se compararon los respondedores y no respondedores a los tratamientos iniciales, y se analizaron los factores de riesgo para la falta de respuesta a los seis meses del tratamiento inicial. Resultados: No se encontraron diferencias en las características basales de los pacientes respondedores y no respondedores, ni en la mayoría de los parámetros de laboratorio o características histopatológicas. Los respondedores presentaron niveles de hemoglobina basal significativamente más altos que los no respondedores 13.5 (±1.5) en comparación con 12.1 (±2.9), respectivamente; p=0.003. La anemia aumentó significativamente el riesgo de no respuesta al tratamiento OR: 8.12 (mínimo: 1.12 - máximo: 66.16), p=0.048. Conclusiones: Los resultados de nuestro estudio sugieren que la presencia de anemia puede ser un factor de riesgo para la falta de respuesta al tratamiento inicial en la FSGS. Aunque se conoce la relación entre la anemia y la fibrosis orgánica, existe incertidumbre sobre la eventual relación fisiopatológica de la anemia con la FSGS o si es incidental debido a su alta prevalencia. Se necesitan más estudios para aclarar estos hallazgos.

ABSTRACT Introduction: Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerulonephrites. Several mechanisms have been proposed that may lead to treatment non-response in primary FSGS, such as the baseline proteinuria amount, histopathological sclerosis rate, and undiagnosed patients with secondary FSGS. This study investigated the possible factors affecting treatment response in primary FSGS. Methods: Our study is a single-center retrospective cohort study that included patients diagnosed with focal segmental glomerulosclerosis by renal biopsies between 2008 and 2018. A total of 185 patients diagnosed with FSGS were identified. The FSGS subtypes of these patients were recorded. There were 57 patients with complete follow-up and treatment histories. Forty-one of these patients were primary FSGS, and 16 were secondary FSGS. Baseline characteristics, laboratory parameters, histopathologic findings, and initial treatments were analyzed in patients with primary FSGS. Responders and non-responders to initial treatments were compared, and risk factors for nonresponsiveness were analyzed in the sixth month of the initial treatment. Results: No difference existed in the responder and non-responder patients' basal characteristics, most laboratory parameters, or histopathologic features. Responders had significantly higher baseline hemoglobin levels than non-responders 13.5 (±1.5) and 12.1 (±2.9), respectively; p=0.003. Anemia significantly increased the risk of treatment nonresponsiveness OR: 8.12 (min: 1.12 - max: 66.16), p=0.048. Conclusions: The results of our study suggest that the presence of anemia may be a risk factor for FSGS initial treatment nonresponsiveness. Although the relationship between anemia and organ fibrosis is known, uncertainty exists about whether anemia is pathophysiologically related to FSGS or incidental due to its high prevalence. More studies are needed to clarify this uncertainty.

Resumen Antecedentes: Tillandsia recurvata colectada en San Luis Potosí, no cuenta con estudios enfocados a su uso como coadyuvante en el tratamiento de la diabetes mellitus. Preguntas y / o Hipótesis: ¿Tillandsia recurvata L. (Bromeliaceae), tendrá actividad antidiabética in vitro e in vivo? Especies de estudio: Tillandsia recurvata L. (Bromeliaceae) Sitio y años de estudio: T. recurvata fue colectada en el municipio de Guadalcazar, San Luis Potosí, México, en diciembre 2021. Métodos: Se evaluó el potencial antidiabético del extracto de metanol de Tillandsia recurvata (TRM) en modelos in vitro e in vivo y se realizó un perfilamiento de los metabolitos secundarios presentes mediante cromatografía de gases acoplada a espectrometría de masas. Resultados: Los resultados demuestran que el extracto reduce eficazmente los niveles de glucosa, triglicéridos y colesterol en sangre in vivo. Además, las pruebas in vitro indican que el extracto reduce la formación de productos finales de glicación avanzada, así como la concentración de metilglioxal y los niveles de hemoglobina glicosilada. El análisis por cromatografía de gases acoplada a espectrometría de masas identificó varios compuestos presentes en el extracto, incluidos: 2-metilbenzaldehído, 4-hidroxi-2-metilacetofenona, 3',5'-dimetoxiacetofenona, ácido pentanóico, ácido palmítico, ácido linoleico, fitol, ácido margárico, oleamida, cis- 11-Eicosenamida, ácido esteárico, 13-Docosenamida, (Z), campesterol y β-sitosterol. Conclusiones: Los resultados obtenidos resaltan el potencial de T. recurvata recolectada en San Luis Potosí como coadyuvante en el tratamiento de la diabetes mellitus, debido a sus propiedades antidiabéticas.

Abstract Background: Tillandsia recurvata collected in San Luis Potosí does not have studies focused on its use as an adjuvant in treating diabetes mellitus. Questions and / or Hypotheses: Will Tillandsia recurvata L. (Bromeliaceae) have antidiabetic activity in vitro and in vivo? Studied species: Tillandsia recurvata L. (Bromeliaceae) Study site and dates: T. recurvata was collected in Guadalcázar municipality, San Luis Potosí, Mexico, in December 2021. Methods: The antidiabetic potential of Tillandsia recurvata methanol extract (TRM) was evaluated using in vitro and in vivo models, and its secondary metabolite content was analyzed using Gas chromatography-mass spectrometry. Results: Results demonstrate that extract reduces blood glucose, triglyceride, and cholesterol levels in vivo. In addition, in vitro tests showed that extract diminished the formation of advanced glycation end products, methylglyoxal concentrations, and glycosylated hemoglobin levels. Gas chromatography-mass spectrometry analysis identified several compounds in the extract, including 2-methylbenzaldehyde, 4-hydroxy-2-methylacetophenone, 3',5' dimethoxyacetophenone, pentanoic acid, palmitic acid, linoleic acid, phytol, margaric acid, oleamide, cis-11-eicosenamide, stearic acid, 13-docosenamide, (Z), campesterol, and β-sitosterol. Conclusions: These results highlight the potential of T. recurvata collected in San Luis Potosi as an adjuvant in treatment of diabetes mellitus.

Resumo Introdução: Disfunção erétil (DE) é um problema sexual comum entre homens com doença renal crônica (DRC). A gravidade da disfunção sexual tende a piorar com a lesão renal. Este estudo tem como objetivo avaliar função erétil e qualidade de vida sexual de pacientes homens adultos com DRC em hemodiálise (HD) em um hospital na Amazônia brasileira. Métodos: Realizou-se estudo quantitativo transversal no Setor de HD da Unidade de Nefrologia, incluindo homens com DRC ≥ 18 anos, submetidos a ≥ 3 sessões semanais de HD por ≥ 3 meses e sexualmente ativos por ≥ 6 meses. Utilizamos o Quociente Sexual Masculino (QSM) para medir satisfação sexual e o Índice Internacional de Função Erétil (IIEF5) para estabelecer função erétil. A análise estatística foi realizada com o SPSS 21.0 usando testes apropriados, como Mann-Whitney e Kruskal-Wallis (P < 0,05). Resultados: Avaliamos 98 pacientes (51,68 ± 15,28 anos). Eles eram predominantemente casados/ou vivendo com um(a) parceiro(a) (60,20%), com tempo de HD entre 1 e 5 anos (55,10%) e KTV médio de 1,17. A prevalência de DE foi 66,30% e foi associada a maior faixa etária (p = 0,01), menor renda familiar (p = 0,02), diabetes (p = 0,01), menor hemoglobina corpuscular média (p = 0,04), maior cálcio total (p = 0,04) e menor albumina (p = 0,03). Aproximadamente 75% classificaram sua vida sexual como regular a excelente. Conclusão: Apesar da elevada prevalência de DE, a maioria dos homens com DRC em HD relatou vida sexual regular a excelente. O estudo ressalta a importância de estabelecer triagem eficaz e realizar avaliações de rotina sobre questões sexuais nesses homens. Introdução (DE DRC. . (DRC) (HD brasileira Métodos Realizouse Realizou se Nefrologia QSM (QSM IIEF5 IIEF (IIEF5 210 21 0 21. apropriados MannWhitney Mann Whitney KruskalWallis Kruskal Wallis P 0,05. 005 0,05 05 0,05) Resultados 9 51,68 5168 51 68 (51,6 1528 15 28 15,2 anos. anos) casadosou casados ou uma um(a parceiroa parceiro parceiro(a 60,20%, 6020 60,20% , 60 20 (60,20%) 55,10% 5510 55 10 (55,10% 117 17 1,17 6630 66 30 66,30 p 0,01, 001 0,01 01 0,01) 0,02, 002 0,02 02 0,02) 0,04, 004 0,04 04 0,03. 003 0,03 03 0,03) 75 excelente Conclusão (DRC (IIEF 2 00 0,0 51,6 516 (51, 152 15, 602 60,20 (60,20% 55,10 551 (55,10 11 1,1 663 66,3 7 0, 51, (51 60,2 (60,20 55,1 (55,1 1, 66, (5 60, (60,2 55, (55, ( (60, (55 (60 (6

Abstract Introduction: Erectile dysfunction (ED) is a common sexual problem among men with chronic kidney disease (CKD). The severity of sexual dysfunction tends to worsen with kidney damage. This study aims to evaluate the erectile function and sexual quality of life of adult male CKD patients undergoing hemodialysis (HD) in a hospital located in the Brazilian Amazon. Methods: A cross-sectional quantitative study was performed within the HD Sector of the Nephrology Unit including men with CKD aged ≥ 18 years, undergoing ≥ 3 weekly HD sessions for ≥ 3 months who had been sexually active for ≥ 6 months. We used the Male Sexual Quotient (MSQ) to measure sexual satisfaction and the International Index of Erectile Function (IIEF5) to establish erectile function. Statistical analysis was performed with SPSS 21.0 using appropriate tests, such as Mann-Whitney and Kruskal-Wallis (P < 0.05). Results: Ninety-eight patients (51.68 ± 15.28 years) were evaluated. They were primarily married/or living with a partner (60.20%), with HD time between 1 to 5 years (55.10%), and an average KTV of 1.17. ED prevalence was 66.30%, and it was associated with a higher age group (p = 0.01), lower family income (p = 0.02), diabetes (p = 0.01), lower mean corpuscular hemoglobin (p = 0.04), higher total calcium (p = 0.04), and lower albumin (p = 0.03). Around 75% classified their sex life as regular to excellent. Conclusion: Despite the high ED prevalence, most men with CKD in HD reported experiencing regular to excellent sex life. The study underscores the importance of establishing effective screening and conducting routine evaluations regarding sexual issues in these men. Introduction (ED CKD. . (CKD) damage (HD Amazon Methods crosssectional cross sectional MSQ (MSQ IIEF5 IIEF (IIEF5 210 21 0 21. tests MannWhitney Mann Whitney KruskalWallis Kruskal Wallis P 0.05. 005 0.05 05 0.05) Results Ninetyeight Ninety eight 51.68 5168 51 68 (51.6 1528 15 28 15.2 evaluated marriedor married or 60.20%, 6020 60.20% , 60 20 (60.20%) 55.10%, 5510 55.10% 55 10 (55.10%) 117 17 1.17 6630 66 30 66.30% p 0.01, 001 0.01 01 0.01) 0.02, 002 0.02 02 0.02) 0.04, 004 0.04 04 0.04) 0.03. 003 0.03 03 0.03) 75 Conclusion (CKD (IIEF 2 00 0.0 51.6 516 (51. 152 15. 602 60.20 (60.20% 551 55.10 (55.10% 11 1.1 663 66.30 7 0. 51. (51 60.2 (60.20 55.1 (55.10 1. 66.3 (5 60. (60.2 55. (55.1 66. ( (60. (55. (60 (55 (6

Resumo Introdução: A deficiência de crescimento na doença renal crônica está relacionada à elevada morbidade e mortalidade. O retardo do crescimento nessa doença é multifatorial. É fundamental conhecer os fatores modificáveis e estabelecer estratégias para melhorar o atendimento às crianças afetadas. Objetivos: Descrever padrões de crescimento em crianças com DRC e fatores de risco associados à baixa estatura. Métodos: Analisamos retrospectivamente dados antropométricos e epidemiológicos, peso ao nascer, prematuridade e níveis de bicarbonato, hemoglobina, cálcio, fosfato, fosfatase alcalina e paratormônio de crianças com DRC estágios 3–5, não submetidas a diálise, acompanhadas por pelo menos um ano. Resultados: Incluímos 43 crianças, a maioria meninos (65%). O escore z médio de altura/comprimento/idade das crianças no início e no acompanhamento foi de –1,89 ± 1,84 e –2,4 ± 1,67, respectivamente (p = 0,011). Cinquenta e um por cento das crianças apresentaram baixa estatura, e essas crianças eram mais jovens que aquelas com estatura adequada (p = 0,027). Níveis de PTH no início do acompanhamento correlacionados com escore z de altura/comprimento/idade. Uma subanálise com crianças menores de cinco anos (n = 17) mostrou que 10 (58,8%) delas apresentaram déficit de desenvolvimento e escore z de peso/idade mais baixo (0,031) e escore z de IMC/idade mais baixo (p = 0,047). Conclusão: Crianças, especialmente mais jovens, com DRC, que não estavam em diálise, apresentaram elevada prevalência de baixa estatura. Níveis de PTH foram correlacionados com escore z de altura, e deficiência de crescimento foi associada a pior estado nutricional. Portanto, é essencial monitorar o crescimento dessas crianças, controlar o hiperparatireoidismo e fornecer suporte nutricional. Introdução mortalidade multifatorial afetadas Objetivos Métodos epidemiológicos nascer bicarbonato hemoglobina cálcio fosfato 35 3 5 3–5 diálise ano Resultados 4 65%. 65 65% . (65%) alturacomprimentoidade altura comprimento idade 189 1 89 –1,8 184 84 1,8 24 2 –2, 167 67 1,67 p 0,011. 0011 0,011 0 011 0,011) 0,027. 0027 0,027 027 0,027) n 17 58,8% 588 58 8 (58,8% pesoidade 0,031 0031 031 (0,031 IMCidade IMC 0,047. 0047 0,047 047 0,047) Conclusão Crianças nutricional Portanto 3– 6 (65% 18 –1, 1, –2 16 1,6 001 0,01 01 002 0,02 02 58,8 (58,8 0,03 003 03 (0,03 004 0,04 04 (65 –1 – 00 0,0 58, (58, (0,0 (6 0, (58 (0, ( (5 (0

Abstract Introduction: Growth failure in chronic kidney disease is related to high morbidity and mortality. Growth retardation in this disease is multifactorial. Knowing the modifiable factors and establishing strategies to improve care for affected children is paramount. Objectives: To describe growth patterns in children with chronic kidney disease and the risk factors associated with short stature. Methods: We retrospectively analyzed anthropometric and epidemiological data, birth weight, prematurity, and bicarbonate, hemoglobin, calcium, phosphate, alkaline phosphatase, and parathormone levels of children with stages 3–5 CKD not on dialysis, followed for at least one year. Results: We included 43 children, the majority of which were boys (65%). The mean height/length /age z-score of the children at the beginning and follow-up was –1.89 ± 1.84 and –2.4 ± 1.67, respectively (p = 0.011). Fifty-one percent of the children had short stature, and these children were younger than those with adequate stature (p = 0.027). PTH levels at the beginning of the follow-up correlated with height/length/age z-score. A sub-analysis with children under five (n = 17) showed that 10 (58.8%) of them failed to thrive and had a lower weight/age z-score (0.031) and lower BMI/age z-score (p = 0.047). Conclusion: Children, particularly younger ones, with chronic kidney disease who were not on dialysis had a high prevalence of short stature. PTH levels were correlated with height z-score, and growth failure was associated with worse nutritional status. Therefore, it is essential to monitor the growth of these children, control hyperparathyroidism, and provide nutritional support. Introduction mortality multifactorial paramount Objectives Methods data weight prematurity bicarbonate hemoglobin calcium phosphate phosphatase 35 3 5 3– year Results 4 65%. 65 65% . (65%) heightlength length age zscore z score followup follow up 189 1 89 –1.8 184 84 1.8 24 2 –2. 167 67 1.67 p 0.011. 0011 0.011 0 011 0.011) Fiftyone Fifty 0.027. 0027 0.027 027 0.027) heightlengthage zscore. score. subanalysis sub analysis n 17 58.8% 588 58 8 (58.8% weightage 0.031 0031 031 (0.031 BMIage BMI 0.047. 0047 0.047 047 0.047) Conclusion Children ones zscore, score, status Therefore hyperparathyroidism support 6 (65% 18 –1. 1. –2 16 1.6 001 0.01 01 002 0.02 02 58.8 (58.8 0.03 003 03 (0.03 004 0.04 04 (65 –1 – 00 0.0 58. (58. (0.0 (6 0. (58 (0. ( (5 (0

Abstract This study aimed to assess the impact of iron fortification in biscuits on nutritional and sensory characteristics, as well as on the hemoglobin levels of consumers. A systematic search strategy was employed to review the literature in Scopus and Web of Science databases, resulting in the identification of 135 articles. These were exported in comma-separated values (CSV) format and selected according to the PRISMA methodology. A bibliometric analysis was conducted using Vosviewer software version 1.6.20, highlighting the temporal evolution of publications and international collaboration. Sixty percent of the studies utilized non-heme iron, derived from legumes and medicinal plants, for the formulation of biscuits. This approach enhanced the content of vitamins, fiber, and minerals, and provided superior flavor and texture compared to heme iron biscuits. It was observed that consuming these biscuits for more than four weeks could double hemoglobin and ferritin levels in the blood, offering significant health benefits, particularly for populations with nutrient deficiencies. Overall, iron fortification has a positive impact on improving nutritional status, particularly among vulnerable groups such as children and pregnant women.

Resumen El objetivo de este estudio fue evaluar el impacto de la fortificación con hierro en galletas sobre las características nutricionales y sensoriales, así como en los niveles de hemoglobina de los consumidores. Se empleó una estrategia de búsqueda sistemática para revisar la literatura en las bases de datos Scopus y Web of Science, lo que ocasionó la identificación de 135 artículos. Estos fueron exportados en formato de valores separados por comas (CSV) y seleccionados de acuerdo con la metodología PRISMA. Se realizó un análisis bibliométrico utilizando el software Vosviewer versión 1.6.20, que destacó la evolución temporal de las publicaciones y la colaboración internacional. El sesenta por ciento de los estudios utilizó hierro no hemo, derivado de legumbres y plantas medicinales, para la formulación de las galletas. Este enfoque mejoró el contenido de vitaminas, fibra y minerales, y proporcionó un sabor y una textura superiores en comparación con las galletas que contenían hierro hemo. Se observó que consumir estas galletas por más de cuatro semanas podría duplicar los niveles de hemoglobina y ferritina en la sangre, ofreciendo beneficios significativos para la salud, particularmente para poblaciones con deficiencias de nutrientes. En general, la fortificación con hierro tiene un impacto positivo en la mejora del estado nutricional, particularmente entre grupos vulnerables como niños y mujeres embarazadas.